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Background: Few studies have examined longitudinal asthma
incidence rates (IRs) from a public health surveillance
perspective.
Objective: Our aim was to calculate descriptive asthma IRs in
children over time with consideration for demographics and
parental asthma history.
Methods: Data from 9 US birth cohorts were pooled into 1
population covering the period from 1980 to 2017. The outcome
was earliest parental report of a doctor diagnosis of asthma. IRs
per 1,000 person-years were calculated.
Results: The racial/ethnic backgrounds of the 6,283 children
studied were as follows: 55% European American (EA), 25.5%
African American (AA), 9.5% Mexican-Hispanic American
(MA) and 8.5% Caribbean-Hispanic American (CA). The
average follow-up was 10.4 years (SD 5 8.5 years; median 5
8.4 years), totaling 65,291 person-years, with 1789 asthma
diagnoses yielding a crude IR of 27.5 per 1,000 person-years
(95% CI 5 26.3-28.8). Age-specific rates were highest among
children aged 0 to 4 years, notably from 1995 to 1999, with a
decline in EA and MA children in 2000 to 2004 followed by a
decline in AA and CA children in 2010 to 2014. Parental
asthma history was associated with statistically significantly

increased rates. IRs were similar and higher in AA and CA
children versus lower but similar in EA and MA children. The
differential rates by sex from birth through adolescence
principally resulted from a decline in rates among males but
relatively stable rates among females.
Conclusions: US childhood asthma IRs varied dramatically by
age, sex, parental asthma history, race/ethnicity, and calendar
year. Higher rates in the 0- to 4-year-olds group, particularly
among AA/CA males with a parental history of asthma, as well
as changes in rates over time and by demographic factors,
suggest that asthma is driven by complex interactions between
genetic susceptibility and variation in time-dependent
environmental and social factors. (J Allergy Clin Immunol
2021;148:1270-80.)
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An incidence rate (IR) is a fundamental epidemiologic measure
that, unlike prevalence, is independent of disease duration and
remission.1 As such, IRs are the most valuable data for generating
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Abbreviations used
AA: African American
aIRR: Adjusted IR ratio
CA: Caribbean American
CREW: Children’s Respiratory and Environment Workgroup
EA: European American
ECHO: Environmental Influences on Child Health Outcomes
IR: Incidence rate
MA: Mexican American

hypotheses related to disease etiology.2 In the United States, there
are legal requirements to report initial diagnoses of most infectious diseases and cancers to public health authorities, which provide national surveillance systems and detailed descriptive data
for these conditions. Routine reporting of IRs according to associated demographic variables from these surveillance systems
over time has been the foundation of numerous hypotheses and
discoveries.3 However, there is remarkably little standardized information regarding IRs for either childhood or adult asthma in
the United States or worldwide.4-9 Although some have proposed
that asthma become a reportable disease,10,11 this idea has never
been promulgated and there are no long-term established US
population–based registries identifying new cases; in contrast,
the National Cancer Institute’s cancer surveillance system has existed since the early 1970s.12,13 A careful search of the literature
has revealed few studies reporting IRs for pediatric asthma.14-23
Most are calculated by using data collected for other purposes
and cover limited calendar time periods, age groups, geographic
areas, and/or racial/ethnic groups.24-28 These IRs are frequently
based on a number of suppositions, such as assuming the timing
of diagnoses to be the midpoint between 2 questionnaires administered over a prolonged time interval or using questionnaires not
specifically designed, standardized, or validated to collect information on the occurrence of asthma. More studies report cumulative incidence measures,29-32 which are a measure of the
proportion of a population that has developed the disease and
which is not a rate but is instead a ratio and a measure of risk.2
Several epidemiologic dogmas exist for pediatric asthma; they
are based largely on prevalence data. For example, it is inferred
from prevalence data33,34 that Puerto Rican children develop
asthma more frequently, followed by Americans of African origin,
Americans of European geographic ancestry, and (least frequently)
Mexican Americans.35,36 Reviews of the scientific literature suggest that asthma prevalence is more common in boys than in girls
until around puberty, at which time the pattern reverses, presumably
because of an increase in asthma IRs among girls.37 Other research
has attempted to evaluate whether the IRs of asthma are changing
for children born in more recent decades, which suggests a need
to investigate changes in the environment occurring during the relevant time periods. Reports have proposed that in the United States
and other developed countries, an increase in asthma occurred in
the 1980s and 1990s and has since plateaued or even decreased,
but most of the data cited to justify these observations come from
health care utilization information or prevalence measures.38-42
To address this knowledge gap, we have calculated asthma IRs
by using pooled birth cohort data from the Children’s Respiratory
and Environment Workgroup (CREW), funded through the
National Institutes of Health Environmental Influences on Child
Health Outcomes (ECHO) program (www.echochildren.org).

CREW brings together a dozen demographically diverse
asthma-focused birth cohorts from across the United States in
an effort to harmonize and subsequently combine data across
these study populations.43 This collaboration allowed retrospective construction of a ‘‘surveillance system’’ for these geographically defined populations of newborns who have been specifically
followed for the development of asthma. This approach is complementary to that of another analysis of asthma IRs in 31
ECHO cohorts that include some CREW cohorts,14 in which
cohort-specific IRs were combined in a meta-analysis as opposed
to being determined by pooling of individual data. The sample
size was larger in the ECHO-wide study; however, its methodologic approach did not permit multivariable modeling or include
calendar year of diagnosis (which is basic to surveillance) or
detailed racial/ethnic categories. Further, in CREW, all the cohorts were focused on asthma and thus included more frequent
survey questions regarding asthma, thereby increasing confidence
in the date of asthma diagnosis.
Our goal was to use the harmonized and subsequently pooled
data across the CREW cohorts to directly calculate overall and
subgroup-specific asthma IRs from 1980 through 2017, with
consideration for the fundamental epidemiologic variables of
time, place, and person.2 An advantage relative to a typical surveillance system is that in the CREW studies the parental history
of asthma was recorded and used as a surrogate for potential genetic susceptibility.44

METHODS
We used data from 9 of the 12 longitudinal US birth cohorts that are part of the
CREW consortium within the ECHO program, which has been described in
detail by Gern et al,43 to examine asthma IRs. Three of the CREW cohorts were
not included because the youngest children were enrolled in relatively recent
years (as late as in 2014, 2016, and 2019, respectively) and could only contribute
minimal person-years of follow-up per child at the time when the data were
harmonized and pooled across cohorts for these analyses. A data sharing protocol
and a data use agreement were approved by the local institutional review boards
for each participating cohort. Each cohort provided data to a single biostatistician
(S.L.H.), who together with the lead epidemiologist (C.C.J.), worked in accordance with a back-and-forth process among the individual cohort data managers
and investigators to address initial differences in the timing and wording of data
collection tools and variations in data management, both before and after the data
were eventually pooled for harmonization. The follow-up data provided from
each cohort were up-to-date as of December 31, 2017.

Demographic variables and definition of outcome
The children included in the IRs were born from 1980 through 2007, and
they were followed through the end of 2017; until a date of asthma diagnosis;
or until they had been dropped from their respective birth cohort because of
loss to follow-up, death, or withdrawal. Geographic locations were classified
according to 3 US regions based on cohort location: Northeast (Baltimore,
Md; Boston, Mass; and New York, NY), Midwest (Detroit, Mich; Cincinnati,
Ohio; Madison, Wis, and St Louis, Mo), and Southwest (Tucson, Ariz). Date
of birth and sex at birth were available for all children. Race/ethnicity was
classified according to 5 self-identified categories: European American (EA),
African American (AA), Caribbean American Hispanic (CA), Mexican
American Hispanic (MA), and other. Children were categorized into these
groups on the basis of their survey data and, in a few instances, on the basis of
further checks with a cohort’s research staff regarding available genetic
ancestry data or other information helpful for this classification. Parental
history of disease was considered positive if either birth parent was reported to
have a history of a doctor diagnosis of asthma.
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IRs per 1000 person-years and 95% CIs derived from 9 CREW cohorts
were computed by cohort and across the combined cohorts by calendar time,
decade of birth, region, age group (0-4, 5-9, 10-14, 15-19, and 20-35 years),
race/ethnicity, child sex, and parental history of asthma. Rates were calculated
first in the standard way, which is often referred to as yielding a ‘‘crude’’ IR and
is defined by the number of new asthma cases divided by the summed personyears at risk during a defined observation time. Censored subjects were
assumed to be disease-free for half of the lost time; for example, a person followed for 1 year but lost to follow-up at year 2 contributed an additional halfyear of disease-free time to the denominator. Rates were then calculated for
each subcategory of interest (eg, calendar time [ranges of years], decade of
birth, geographic region, age, race/ethnicity, sex, and parental history of
asthma). Decade born can suggest hypotheses related to environmental
changes that may have affected all age groups over the time period followed.
Stratified tables are presented for ease of interpretation. Multivariable Poisson
regression models involving use of the robust Huber-White sandwich variance
estimator were used to calculate adjusted IR ratios (aIRRs) and 95% CIs.45,46
All adjusted models included the following variables as potential confounders:
decade of birth, region, age, race/ethnicity, sex, and parental history of asthma.
Parental history of asthma, child sex, race/ethnicity, age, region, and decade of
birth were analyzed as potential effect modifiers.

person-years during this time period and a peak at 41.9 per
1000 person-years in the period from 2005 to 2009 (95% CI 5
38.9-45.2). However, whereas the proportions by child sex remained constant in the cohorts over calendar time, the cohorts
born earliest came from general population sampling frames
(rather than being required to have a family history of asthma
or allergies) and were predominantly of European ethnicity (see
Fig E2 in this article’s Online Repository at www.jacionline.
org), with both variables associated with lower IRs (Table I and
see Tables E2 and E3 in this article’s Online Repository at
www.jacionline.org). Therefore, subsequent analyses by calendar
time and decade of birth stratified the data by race/ethnicity and
parental history.
Interestingly, the IRs were nearly identical and more than
doubled for AAs and CAs (51.4 per 1000 person-years [95% CI 5
47.0-56.0] and 51.7 per 1000 person-years [95% CI 5 44.7-59.5],
respectively) as opposed to nearly identical rates in EAs (20.6 per
1000 person-years [95% CI 5 19.2-22.1]) and MAs (21.3 per
1000 person-years [95% CI 5 18.1-24.9]) (Table I). When the
data were stratified by parental history and sex, the IRs in each
parallel stratum were similar and higher in AAs and CAs,
compared with similarly lower rates in EAs and MAs (see
Table E3). We also compared IRs for these 4 race/ethnicity groups
by age (Fig 1) and found parallel patterns in the age-specific rates.
Thus, for ease of interpretation and to increase the statistical power and precision of the estimates related to other variables, we
collapsed these 4 race/ethnic groups into 2, deemed AAs/CAs
and EAs/MAs (for sex- and parental history–specific IRs and
age- and parental history–specific IRs, respectively, for these 2
combined race/ethnicity groups, see Table E4 and Fig E3 [in
this article’s Online Repository at www.jacionline.org]).

RESULTS
Table I shows the characteristics of the children included in the
analyses and crude IRs (for information by individual cohort, see
Table E1 and Fig E1 in this article’s Online Repository at www.
jacionline.org). The 37-year time period of observation for
asthma diagnosis ranged from 1980 to 2017 for the 6283 children,
with the most person-years of observation between 2000 and
2009. The average person-time contributing to the sample for
these analyses, starting at birth (birth years ranged from 1980 to
2007) was 10.4 years (SD 5 8.5 years; median 5 8.4 years) for
a total of 65,291 person-years. At last date of follow-up in
2017, the oldest cohort participants had reached 34.8 years, and
the youngest were 12.7 years.
In the combined cohorts at time of birth, 55% of the children
were EA, 25.5% were AA, 9.5% were MA, and 8.5% were Puerto
Rican or Dominican (CA). Other race/ethnic groups comprised
only 1.5% of the population and were excluded from further
analyses. Of the 9 cohorts, 4 required a parental allergic history
(asthma, allergy, or sensitization) with varying definitions for
eligibility (see the section Description of Individual Cohorts in
the Online Repository at www.jacionline.org). When the pooled
data were used, a parental history of asthma (mother, father, or
both) was reported by 37.2% of the parents across all the cohorts.
There were 1798 cases of physician-diagnosed asthma, with an
overall crude IR of 27.5 per 1000 person-years (95% CI 5 26.328.8) (Table I). When calendar period of the diagnoses was
considered, the rates were highest from 1995 to 2009, with all
of the year categories having an IR of more than 25 per 1000

Analyses of IRs by calendar time and place
The first step in analyzing surveillance data is usually to
evaluate IR patterns by year and geographic region (see Figs E4
and E5 in this article’s Online Repository at www.jacionline.
org). In Fig E4, it is evident that those with a parental history of
asthma had higher rates over time for both race/ethnicity categories, and Fig E5, A-D shows IRs by Midwest versus Northwest
versus Southwest over time, as stratified by parental history and
the 2 race/ethnicity categories. However, differences in age distribution of populations being compared affect interpretation if rates
vary by age. In this ‘‘constructed’’ population, new birth cohorts
were initiated as the years progressed, as a result of which the
age distribution of the pooled cohort changed over the years.
Therefore, age-specific rates are presented in Fig 2, A-D,
revealing different patterns by age and calendar year, race/
ethnicity, and parental history. The 0- to 4-years age group
showed high rates in the period from 1995 to 1999 that were
consistent in all race/ethnicity categories and parental history
groups. Among the EA/MAs, the 5- to 9-year-olds and 10- to
14-year-olds group rates peaked earlier than did the 0- to 4years age group and then declined (see also Fig E6, A and B in
the Online Repository at www.jacionline.org). Although unstable
before 1995, the IRs in the 0- to 4-year-olds age group were much
higher among AAs/CAs with a parental history of asthma than in
the other groups. It appears in this AA/CA group that rates peaked
in the period from 1990 to 1994, remained high (with IRs higher
than 130.0 from 1995 to 2009), but then decreased and were
similar to the rates for the other race/ethnic categories after

An incident case of asthma was defined as the first occurrence of an asthma
diagnosis by a doctor based on the date of diagnosis as reported by a parent
(usually the mother). If the exact date of diagnosis was not recalled, it was
assumed to be at the median point between the date of administration of the
questionnaire on which the diagnosis was reported and the previous
questionnaire. Our objective was to retrospectively construct population
data and incident cases as they would have been collected by a public health
surveillance system that accepts results from physicians and/or associated
medical laboratories without future modifications; therefore, we did not place
any restrictions on these first reports.

Statistical analyses
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TABLE I. Overall univariate crude doctor-diagnosed asthma IRs per 1000 person-years, by epidemiologic characteristics
Characteristic

No. (%)

All subjects
Calendar time of surveillance*
1980-1984
1985-1989
1990-1994
1995-1999
2000-2004
2005-2009
2010-2014
2015-2017
Decade born
1980-1989
1990-1999
2000-2009
Geographic region
Northeast
Midwest
Southwest
Child age during follow-up (y)*
0-4
5-9
10-14
15-19
20-35
Child race/ethnicity
EA
AA
MA
CA
Other
Child sex
Male
Female
Parental history of asthma
None
Paternal only
Maternal only
Both parents
Either or both parents

Person-years

No. of asthma cases

IR (95% CI) per 1,000 person-years

65,291

1,798

27.5 (26.3-28.8)

2,860
6,123
7,690
8,609
13,056
16,286
8,761
1,904

19
123
178
262
357
683
152
24

6.6
20.1
23.1
30.4
27.3
41.9
17.3
12.6

2,058 (32.6)
1,098 (17.5)
3,127 (49.8)

33,731
11,169
20,391

562
390
846

16.7 (15.3-18.1)
34.9 (31.5-38.6)
41.5 (38.7-44.4)

1,535 (24.4%)
3,044 (48.5%)
1,704 (27.1%)

13,646
25,404
26,240

622
706
470

45.6 (42.1-49.3)
27.8 (25.8-29.9)
17.9 (16.3-19.6)

6,283
4,365
2,815
1,649
712

(100%)
(69.5%)
(44,.8%)
(26.2%)
(11.3%)

25,520
17,549
10,471
5,950
5,800

1,011
440
188
77
82

39.6
25.1
18.0
12.9
14.1

(37.2-42.1)
(22.8-27.5)
(15.5-20.7)
(10.2-16.2)
(11.2-17.5)

3,268
1,515
563
505
92

(55.0)
(25.5)
(9.5)
(8.5)
(1.5%)

40,184
9,813
7,338
3,789
955

829
504
156
196
17

20.6
51.4
21.3
51.7
17.8

(19.2-22.1)
(47.0-56.0)
(18.1-24.9)
(44.7-59.5)
(10.4-28.5)

3,172 (50.5)
3,110 (49.5)

30,901
34,389

984
814

31.8 (29.9-33.9)
23.7 (22.1-25.4)

3,401
645
1,028
198
2,017

41,344
6,308
8,342
1,248
16,927

725
239
422
106
831

17.5
37.9
50.6
84.9
49.1

6,283
1,225
1,884
1,777
2,494
3,813
4,628
2,507
1,204

(19.5%)
(30.0%)
(28.3%)
(39.7%)
(60.7%)
(73.7%)
(39.9%)
(19.2%)

(64.5)
(12.2%)
(19.5%)
(3.8%)
(37.2)

(4.0-10.4)
(16.7-24.0)
(19.9-26.8)
(26.9-34.3)
(24.6-30.3)
(38.9-45.2)
(14.7-20.3)
(8.1-18.8)

(16.3 -18.9)
(33.2 -43.0)
(45.9 -55.7)
(69.5-102.7)
(45.8-52.5)

Child sex missing for 1 child, race/ethnicity missing for 432 children, and parental history of asthma missing for 1,011 children.
*The population numbers in the asterisk-prefaced categories are not mutually exclusive; children in the cohorts were followed as they aged over calendar time from the point of
enrollment (birth date) until they were censored owing to cessation of follow-up or asthma diagnosis.

2010. Thus, the changes in IRs over calendar time have been
greatest in the 0- to 4-year-olds and highest from 1985 to 2009
for AA/CAs with a parental history of asthma. Detailed calendar
time–, decade of birth–, age-, sex-, race/ethnicity-, and parental
history–specific rates are provided in Table E5 (in this article’s
Online Repository at www.jacionline.org).

Analyses of IRs by birth decade
IRs were examined next by decade of birth, race/ethnicity, and
parental history (Fig 3). Although the IRs by race were similar
among those without a parental history of asthma in the decade
from 1980 to 1989, they diverged in the 2 subsequent birth decades, with higher IRs for AAs/CAs. For those with a parental history of asthma, the IRs for AAs/CAs were markedly higher than
were those for EAs/MAs in all 3 birth decades examined. However, the IRs for EAs/MAs with a positive parental history increased
by birth decade, whereas those of the AAs/CAs peaked in the
decade from 1990 to 1999.

With regard to age, the most striking changes in rates by
decade of birth were found in the 0- to 4-years age groups
(Fig 4). Among those without a parental history of asthma, 0to 4-year-olds from both race/ethnicity groups born in the
1990s had the highest IRs when compared with the IRs
among those born in the other 2 decades and all other age
groups (Fig 4, A and B). Among those with a parental history
of asthma, the EAs/MAs aged 0 to 4 years once again had the
highest IRs during the decade from 1990 to 1999, but the
AAs/CAs aged 0 to 4 years had higher IRs in the decade
from 1980 to 1989, with their IRs declining dramatically in
the subsequent 2 decades, although among the studied cohorts
fewer AAs/CAs were enrolled in the 1980s, thus impairing
the precision of the IR estimates for that decade. Nevertheless, the rate for AAs/CAs aged 0 to 4 years and born in
the 1990s was striking at 150.5 (95% CI 5 107.5-204.9)
per 1000 person-years, which is nearly 3 times the rate for
EAs/MAs of the same age (57.6 [95% CI 5 45.9-71.3] per
1000 person years).
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FIG 1. Doctor-diagnosed asthma IRs per 1000 person-years, by age and 4 individual race/ethnicity
categories (N 5 5035).

FIG 2. Doctor-diagnosed asthma IRs per 1000 person-years by calendar time (years) and age at diagnosis
and by race/ethnicity and parental history of asthma (N 5 5035).

Analyses of IRs by age, race, and sex
Differences in asthma patterns by sex and age have been of
continuing scientific interest (Fig 5, A-D). In subjects without a
parental history of asthma (Fig 5, A and B), the rates among the

EA/MA females increased slightly from the age range from 0 to
4 years to the age range from 10 to 14 years, after which they plateaued. The rates among males declined from the age range from
0 to 4 years to the age range from 15 to 19 years, crossing the rates
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FIG 3. Doctor-diagnosed asthma IRs per 1000 person-years by decade of birth and by race/ethnicity and
parental history of asthma (N 5 5035).

FIG 4. Doctor-diagnosed asthma IRs per 1000 person-years by decade of birth and age at diagnosis and by
race/ethnicity and parental history of asthma (N 5 5035).

for females during the 10- to 14-year interval. In contrast, the rates
for AAs/CAs were highest in 0-year-old to 4-year-old children for
both males and females, and although the data are sparse, the
trends suggest that the rates initially declined during the interval
from 0 to 4 years but then increased in males after 9 years and in
females after 14 years. In those with a parental history of asthma
(Fig 5, C and D), the rates were exceedingly high in 0- to 4-yearold AA/CA males (;150 per 1000 person-years) and were also
high in AA/CA females in this age group (;100 per 1000
person-years), after which they rapidly declined but did not cross
each other. Among the EAs/MAs with a parental history of
asthma, there was a crossover in incidence by sex at an older

age than found among those without a parental history of asthma
and predominately reflected a more rapid decrease in the male
rates rather than an increase in the rates among females.

Multivariable analyses
aIRRs were calculated by using Poisson models to account for
potential confounders and assess effect modification. The columns devoted to model 1 in Table II display aIRRs for the total
population, demonstrating that being born in the 1990s, younger,
AA/CA, and male and having a parental history of asthma were all
significantly (P < .001) associated with higher aIRRs of asthma.
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FIG 5. Doctor-diagnosed asthma IRs per 1000 person-years by age and child sex and by race/ethnicity and
parental history of asthma (N 5 5034).

A sex-by-race/ethnicity term in this model was not significant
(P 5 .856), nor was the sex-by–family history term (P 5 .496).
However, because the parental history of asthma–by-race/
ethnicity interaction term was significant at (P 5 .025), models
2 and 3 assess effect modification by parental history of asthma.
AA/CA race/ethnicity is a stronger risk factor in those with a
parental asthma history (aIRR 5 2.16 [95% CI 5 1.76-2.64]),
whereas the higher-incidence birth decades (ie, the 1990s and
2000s) seemed more important among individuals without a
parental history of asthma. The rate increases in the 0- to 4years and 5- to 9-years age groups were stronger in those with a
parental history of asthma. Models 4 and 5 stratify by decade of
birth because the decade born–by-region interaction term was significant at P < .001, which was not unexpected, as there were
fewer AAs/CAs and northeastern US cohorts born in the 1980s
than in the 1990s and 2000s in this study. For those born in the
1980s, the 5- to 9-year-olds and 10- to 14-year-olds groups had
the highest rates, rates in the Southwest region were higher than
in the Midwest, and the aIRR for parental history of asthma
was 2.19 (95% CI 5 1.81-2.65). For those born from 1990 to
2009, the aIRR was notably elevated for the 0- to 4-year-olds
(aIRR 5 5.08 [95% CI 5 2.77-9.30]), rates were significantly
lower in the Southwest; males and AAs/CAs had increased rates,
whereas parental history of asthma maintained a similar
association.

DISCUSSION
The IR, which is defined as the number of new cases of a
disease over a specified time period occurring in a defined
population at risk for the disease, is a fundamental measure in
epidemiology because IRs are critical for understanding disease
etiology and causality.47 Other epidemiologic measures, such as
mortality rates and prevalence ratios, are less valuable in relation

to causality because many factors beyond etiology come into play
with these estimates. By measuring childhood asthma IRs over a
nearly 40-year period, we found that the rates revealed marked
differences over calendar time, as well as by age, racial/ethnic
background, sex, and parental history of asthma.
The most highly cited study providing IRs for pediatric asthma
in the United States and covering the period from 1964 to 1983
was published in 1992 by Yunginger et al from the Mayo Clinic.7
The population was 97% White and living in a county of only
about 100,000 residents in 1980. This landmark study lacked information on parental history of asthma. Nevertheless, it suggested that the incidence of asthma was increasing in the period
just preceding that in which our data collection was initiated,
with rates in the early 1980s comparable to those found in our
EA/MA population at that time. In addition, the largest increases
over calendar time were in children aged 0 to 14 years, particularly in those aged 1 to 4 years, which was similar to our findings
(see Fig E6, A and B for CREW EA–only IRs by calendar time
and age comparable to those found in the Yunginger et al7 study).
The peak rate for children aged 1 to 4 years in Olmstead County in
1983 was approximately 10 per 1000 person-years, compared
with 6.8 per 1000 person-years in the period from 1980 to 1984
for our EA/MA group, which consisted of children from the
earliest Tucson-based cohort. The Mayo group also saw differential IRs over time for males and females depending on age, with
the increase in incidence over time greater in males aged 1 to 9
years (and especially in those aged 1 to 4 years) but not in older
age groups.
Many questions have been raised regarding the effects of race
and ethnicity on epidemiologic and clinical aspects of pediatric
asthma. Among the cohorts analyzed in this study, there were
minimal differences in IRs among those considering themselves
to be predominately EA and those considering themselves to be
MA. Similarly, there were minimal differences among those
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TABLE II. aIRRs of doctor-diagnosed asthma by Poisson regression model, total and stratified by parental history and birth
decade

Characteristic

Decade born
2000-2009
1990-1999
1980-1989
Region of
United States
Northeast
Midwest
Southwest
Age group
Age (y)
0-4
5-9
10-14
15-35
Race/ethnicity
AA/CA
EA/MA
Sex
Male
Female
Parental asthma
history
Yes
No

Model 5
Born 1990-2009
(n 5 3251)

Model 4
Born 1980-1989
(n 5 1783)

Model 3
With parental
history (n 5 1849)

Model 2
Without parental
history (n 5 3185)

Model 1*
All (N 5 5034)
aIRR (95% CI)

P value

aIRR (95% CI)

P value

aIRR (95% CI)

P value

aIRR (95% CI)

P value

aIRR (95% CI)

P value

1.13 (0.95-1.33)
1.32 (1.11-1.59)
Reference

.168
.002

1.29 (1.03-1.62)
1.46 (1.09-1.96)
Reference

.028
.012

0.94 (0.72-1.23)
1.16 (0.89-1.51)
Reference

.670
.274

—
—
—

—
—
—

—
—
—

—
—
—

1.07 (0.88-1.29)
0.99 (0.85-1.14)
Reference

.496
.839

1.18 (0.86-1.62)
0.96 (0.80-1.16)
Reference

.303
.690

1.05 (0.80-1.40)
1.06 (0.83-1.35)
Reference

.706
.621

1.83 (1.51-2.23) <.001
1.24:(1.01-1.53) .039
1.18 (0.94-1.48) .149
Reference

1.42 (1.11-1.82)
1.14 (0.88-1.47)
1.18 (0.90-1.56)
Reference

.005
.333
.227

2.68 (1.87-3.84)
1.61 (1.11-2.35)
1.33 (0.88-2.01)
Reference

<.001 0.84 (0.65-1.10) .216 5.08 (2.77-9.30) <.001
.012 1.73 (1.37-2.18) <.001 2.32 (1.25-4.29) .007
.173 1.56 (1.21-2.00) .001 1.71 (0.89-3.30) .106
Reference
Reference

1.89 (1.62-2.20) <.001
Reference

1.56 (1.24-1.98)
Reference

<.001

2.16 (1.76-2.64)
Reference

<.001 1.17 (0.64-2.13)
Reference

.610

1.58 (1.38-1.80) <.001
Reference

1.39 (1.25-1.54) <.001
Reference

1.33 (1.15-1.55)
Reference

<.001

1.43 (1.24-1.65)
Reference

<.001 1.14 (0.96-1.36)
Reference

.136

1.52 (1.33-1.73) <.001
Reference

2.16 (1.93-2.42) <.001
Reference

—
—

—
—

—
—

—
—

0.76 (0.62-0.92)
Reference

—
.006

1.86 (1.39-2.48) <.001
1.51 (1.15-2.00) .003
Reference

2.19 (1.81-2.65) <.001 2.11 (1.83-2.42) <.001
Reference
Reference

In each model, all variables have been adjusted for all the other variables in the model.
*For model 1, the aIRR of the decade from 2000 to 2009 decade as compared with the decade from 1990 to 1999 decade is 1.10 (95% CI 5 0.94-1.29); P 5..220.
There were insufficient numbers to permit an estimate.

considering themselves AA and those identifying as being of CA
heritage (in this study, largely children of Dominican or Puerto
Rican origin). These findings differ from those of several studies
of prevalence reporting that among children, asthma prevalence
is highest among Puerto Rican children, followed by Black and
White children and lowest among Hispanic children of Mexican
heritage.39,48-52 The apparent differences between the incidence
and prevalence findings could be related to variation in
remission rates. Some long-term cohort studies have shown
that asthma is variably present throughout life, with more
remissions during childhood53-55; however, there is little information on whether asthma remission varies among racial/ethnic
groups.56 Hispanic populations from the Caribbean in general,
and specifically from Puerto Rico and the Dominican Republic,
have been shown to have a large percentage of African ancestry,
whereas MAs do not.57,58 These findings, along with the very
high IRs in the youngest age group of AA/CA children with
parental histories of asthma and the minimal geographic
variation, suggest that there may be a factor associated with
African ancestry that increases the risk of asthma inception.59
However, although genetics likely play a role, numerous
nongenetic factors associated with race/ethnicity in the United
States over multiple generations appear critically important
and certainly contribute to the observation that positive asthma
family history is a potent influence on IRs. Moreover, the dramatic changes in asthma IRs over just a few decades that vary
by race/ethnicity suggest that environmental exposures and
social circumstances contribute substantially to disease risk.60

An important question arising from monitoring asthma
prevalence concerns the increase in prevalence during the
1990s and 2000s followed by an apparent plateau or decline
afterward. Our data show a marked decline in the IRs of asthma
from the period from 2005 to 2009 to the period from 2010 to
2014 among AA/CA children with parental histories of asthma,
which occurred similarly in the 3 areas of the United States
considered. This change occurred predominately among
children younger than 4 years. The declining incidence during
these years is also clearly seen among AA/CA children without
a parental history of asthma, and to a lesser degree in the other
race/ethnicity–parental history groups. Among EA/MA
children, the peak IRs among 0- to 4-year-olds occurred from
1995 to 1999 but took place earlier for the 5- to 9-year-olds
group (1985-1989). A study by Engelkes et al examined asthma
IRs among 5- to 18-year-old children in The Netherlands from
1999 to 2012 and reported an apparent decline from 2007 to
2012 with a pivot point of 2008-2009, supporting our findings.20
Another study of asthma IRs in Denmark and Sweden showed
an increase in asthma incidence from 1998 to 2006 followed
by a similar decline to 2011 in the Danish children that stood
in contrast to an increase in incidence from 2006 to 2010 in
the Swedish children.21 Simpson et al in England61 reported a
decline in asthma incidence in all age groups from birth to
age 65 years and older from 2001 to 2005 and especially in
2005; similarly, the largest declines were also seen in children
aged 0 to 4 years (–38.4%) and in children aged 5 to 14 years
(–27.0%).
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The pattern of uptick and then decline in asthma IRs over time
and by decade born suggests that 1 or more novel external factors
were increasingly introduced in the 1980s and more dramatically
influenced 0- to 4-year-old children and all racial groups, but
especially those of African heritage and those with a parental
history of asthma. This factor may have then changed in a way that
substantially reduced the number of new childhood asthma
diagnoses both in Europe and across the United States, with the
decline first witnessed among US children of European origin. It
remains for investigators to consider and evaluate possible reasons
for such a change. A strong candidate as 1 such factor is the
changing use of antibiotics during early infancy in response to
antimicrobial stewardship promotion, an exposure that has been
examined in the past with respect to risk of allergies and asthma
with conflicting results.62-64 In a 2020 comprehensive article, Patrick et al reported that according to health care administrative data,
antibiotic prescribing to children in the province of British
Columbia, Canada, who were younger than 1 year had declined
by 77% from 1996 to 2016, and from 2000 to 2014, this decline
was associated with a significant decrease in asthma diagnoses in
children from the age 1 to 4 years.65 Moreover, in the Canadian
CHILD cohort, use of systemic antibiotics before 1 year of age
was associated with significantly increased risk for an asthma diagnosis at age 5 years, which was shown to be mediated by the gut
microbial community at age 1 year. Interestingly, a US study of
claims data across 9 health plans showed a significant decrease
(24%) in antibiotic medications dispensed to children in the age
group from 3 months to 3 years between 1996 and 2000.66 Further,
over this period of time, many other exposures potentially related to
the infant gut microbial community and/or childhood asthma risk
have changed; these factors include types and quantities of air
pollution, chemicals in foods and on clothing, microbes in food,
decreased numbers of early infections and changes in pediatric
vaccines, medically based campaigns to alter infant care, drinking
water quality, and physical activity levels.67,68
One of the more consistent findings in the prevalence data is a
decline in the prevalence of asthma in males during the midteenage years and an increase in prevalence among females.
Many have assumed that this change resulted from an increase in
IRs among females related to puberty. However, our data do not
show a large increase in IRs among females approaching the
teenage years. Among AA/CA children, the incidence for males is
always greater or the same as that for females, although our data
were limited for AA/CA children in the older age groups. Among
the EA/MA subjects, the IRs for males and females do cross
between 10 and 19 years for those with and without a parental
history of asthma, but the change in IRs is primarily due to a rapid
decline in the IRs in males after the first decade, with little change
in females. This same pattern of a higher male incidence that
declines rapidly between 10 and 20 years of age to fall below the
incidence for females has been reported by others.20,22,28 It has
been suggested that older females may be more likely to develop
non–IgE-related asthma, which would then be reflected in overall
asthma age-specific IRs and prevalence, highlighting the need for
more precise asthma phenotyping in epidemiologic studies.69,70
Strengths of our study include the large, racially/ethnically and
geographically diverse cohorts of subjects who were recruited
over the course of more than 30 years and were specifically
followed frequently and queried about allergic diseases and
asthma. The pooling and harmonization of data from these 9
cohorts allowed relatively robust estimates of asthma IRs over 3
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decades, with consideration of the child’s age, race/ethnicity, sex,
and region of birth within the United States, as well as parental
history. Although it is known that the incidence of an asthma
diagnosis among children 0 to 4 years of age may often be a
transient wheezing phenotype,71 our intent was to evaluate
asthma IRs as they would appear if an asthma diagnosis were a
reportable event as part of a routine surveillance system covering
all asthma diagnoses and therefore all phenotypes. However, it is
reassuring that our results do not conflict with the aforementioned
ECHO-wide incidence study,14 in which a case among children
with a diagnosis of asthma or wheeze before the age of 5 years
was not considered an incident case at that time point unless there
also was sustained evidence of disease after the fifth birthday.
As with all studies, ours had important limitations. There were
minor variations between studies in the specific questions asked
about asthma diagnosis that had to be reconciled by expert opinion as
the data were harmonized. Because these were longitudinal studies of
large populations, there were inevitable losses to follow-up in each
cohort. Similarly, missing data reduced the numbers of subjects for
certain analyses. Just US populations were considered, and they were
restricted to only 8 states. Determinations of race and ethnicity were
dependent on the parental reports rather than on ancestral DNA
markers. As already mentioned, the racial/ethnic makeup of cohorts
and their selection criteria varied over the decades of recruitment,
making the early-period estimates of IRs for non-EA groups less
robust. It is also impossible to ascertain how changes in the diagnostic
criteria for asthma over time, by racial group, or by region of the
country affected our results. However, it is unlikely that national or
local diagnostic trends would have systematically influenced only
certain subgroups (particularly by age), as was revealed by our data,
suggesting that this may be less of a concern. It would have been
valuable to have information on other variables such as allergic
sensitization and sequential spirometry to provide more specific
phenotypes, but this awaits future analyses, as these data, which are
also less widely available, have not yet been harmonized.
In summary, we found that asthma IRs varied dramatically by
age, sex, racial/ethnic background, and parental history of asthma.
The highest asthma IRs were among AA/CA children 0 to 4 years
of age—especially males who had parental histories of asthma. We
found that these variables affected rates in both males and females
but especially in preschool males. Asthma IRs also varied by
decade of birth, with a peak in births in the 1990s. The increase and
relatively high IRs for asthma followed by declines suggest that it
would be valuable to search for environmental and behavioral
changes occurring during the relevant time periods. Importantly,
our findings illustrate the potential value of a US asthma surveillance system for discerning patterns and generating etiologic
hypotheses that could lead to disease prevention.
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Key messages
d

Childhood asthma IRs in the United States have varied
dramatically by age, racial/ethnic background, child sex,
and parental history.

d

Asthma IRs were highest in 0- to 4-year-olds, particularly
among AA/CA males with a parental history of asthma,
but rates for this race/ethnic category declined after
2009. A defined peak for EA/MA 0- to 4-year-olds
occurred in 1995-1999.
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